Hologic (HOLX) Akcie Kurz
Hologic Kurz
Za posledních 19 let vzrostly tržby Hologic o 12,2 % ročně a dosáhly 4,10 Mld. USD. Zisk na akcii rostl o 12,8 % ročně za posledních 19 let. U Hologic je čistá marže 13,8 % dolů oproti 33,2 % před několika lety. Konsenzuální 12měsíční cílová cena pro Hologic je 77,52 USD, asi nad cenu o 2,0 %. Z 23 analytiků jich 0 doporučuje nákup — celkový konsenzus je Držet.
Cena akcie Hologic
Obchodní model Hologic a analýza akcií
Nejčastější otázky týkající se akcie Hologic
The main competitors of Hologic Inc in the market include companies like Abbott Laboratories, Thermo Fisher Scientific, and Becton, Dickinson and Company.
The business model of Hologic Inc revolves around providing innovative diagnostic solutions, primarily focused on women's healthcare. Hologic develops and markets a wide range of medical devices and instruments, including imaging systems, surgical products, and molecular diagnostic assays. The company's products are designed to enable healthcare professionals to effectively screen, diagnose, and treat various conditions and diseases. Hologic is renowned for its advanced technologies in breast health, gynecology, and skeletal health, offering solutions that empower early detection and intervention. By constantly pushing the boundaries of medical technology, Hologic Inc remains committed to improving healthcare outcomes for women around the world.
Hologic Inc is primarily active in the healthcare industry, specifically in the field of diagnostic products and medical devices. With a focus on improving women's health, Hologic Inc develops and manufactures a wide range of innovative solutions. Their portfolio includes advanced imaging systems, molecular diagnostic assays, surgical instruments, and women's health screening tests. As a prominent player in the healthcare sector, Hologic Inc constantly strives to provide cutting-edge technologies and solutions to address various medical challenges.
Hologic Inc is a leading global healthcare and diagnostics company. Established in 1985, Hologic has excelled in providing innovative solutions for women's health, with a focus on early detection and treatment of breast and cervical cancers. The company's dedication to research and development has resulted in breakthrough technologies, including the introduction of the first 3D mammography system. Hologic has expanded its portfolio to include diagnostics, surgical and skeletal health, and GYN surgical products. With a strong commitment to advancing healthcare, Hologic Inc continues to make significant contributions to improving patient outcomes and quality of life.
Hologic Inc, a leading healthcare company, has achieved several significant milestones. In recent years, the company has made notable advancements in breast health solutions. They introduced the world's first 3D mammography system, which revolutionized breast cancer detection by providing clearer and more accurate images. Hologic Inc also developed the Genius™ 3D Mammography™ exam, proven to detect breast cancer at an earlier stage compared to 2D mammography alone. Furthermore, the company expanded its portfolio by acquiring Gen-Probe, a molecular diagnostics company, allowing Hologic Inc to offer a comprehensive range of diagnostic solutions. These milestones highlight Hologic Inc's commitment to innovation and improving women's healthcare outcomes.
Hologic Inc is primarily present in various countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered. Additionally, Hologic Inc operates in Europe, including countries like Germany, France, Italy, and the United Kingdom. It also has a presence in Asia, particularly in countries such as China and Japan. Furthermore, Hologic Inc serves customers in Canada and Latin America, with a focus on countries like Mexico and Brazil. Overall, Hologic Inc has a global reach and aims to provide its products and services to diverse markets internationally.
Hologic Inc represents values of innovation, commitment to quality, and patient-centric approach. The corporate philosophy of Hologic Inc revolves around developing cutting-edge medical technologies to improve women's health outcomes. With a focus on providing accurate and reliable diagnostic solutions, Hologic Inc strives to empower healthcare professionals and patients alike. The company's dedication to research and development, evidence-based practices, and collaboration with healthcare experts reinforces its commitment to advancing healthcare for women globally. Hologic Inc's mission is to make a difference in people's lives through advanced healthcare solutions, making them a trusted and reliable leader in the industry.
Analytici aktuálně stanovují průměrnou cílovou cenu 76,66 USD pro akcii Hologic (medián: 77,52 USD), tedy +0,9 % vůči poslední ceně. Konsensus vychází z 23 hodnocení analytiků.
23 analytiků aktuálně hodnotí akcii Hologic: 0 doporučuje koupit, 20 držet a 3 prodat. Pro rok 2026 analytici očekávají u Hologic tržby 4,24 Mld. USD a zisk na akcii 4,49 USD.
Při aktuálním kurzu se akcie Hologic obchoduje za 67,91 EUR (76,01 USD).
Akcie Hologic (HOLX) je kótována na 9 burzách, mimo jiné: NASDAQ (HOLX), London (0J5Q.L), SIX (Zürich) (HO1.SW), XETRA (HO1.DE), Frankfurt (HO1.F), München (HO1.MU), Düsseldorf (HO1.DU), Wien (HOLX.VI).
Hologic Inc is an international leading provider of medical technology products and solutions. The company, headquartered in Marlborough, Massachusetts, operates globally and is divided into four business segments: Diagnostics, Gynecology, Skeletal Health, and Aesthetics.
Tržby očekávané za Hologic činí 4,24 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Hologic činí 1,01 Mld. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Hologic je aktuálně 16,93. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Hologic.
Poměr ceny k tržbám (P/S) Hologic je aktuálně 4,05. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Hologic.
Score kvality pro Hologic je 1/10.
ISIN Hologic je US4364401012. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Hologic je 879100. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Hologic je HOLX. Symbol tickeru se používá k obchodování akcií Hologic na burze.
Hologic akcie
Hologic Peer Group
Hologic Ticker
Hologic FIGI
Všechny fundamentální údaje o Hologic v podrobné analýze
Naše analýzy akcií společnosti Hologic zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Hologic. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: